Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Clinical Trial Eye Lipid Mobilizer (ELM) Using Heat and Vibration for the Treatment of Meibomian Gland Dysfunction (MGD)

NCT06242860 is registered in ClinicalTrials.gov with Eyedetec Medical, Inc. as lead sponsor.

NCT NCT06242860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06242860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Clinical Trial Eye Lipid Mobilizer (ELM) Using Heat and Vibration for the Treatment of Meibomian Gland Dysfunction (MGD)
Lead sponsor
Eyedetec Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2022
Completion date
March 14, 2022
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaporative dry eye disease, meibomian gland dysfunction